FDA kicks off review of CBD with 140 people scheduled to testify at first public hearing Friday

The cannabis industry wants a single set of rules, but entrepreneurs aren’t sure what those rules should be.

At Friday’s landmark cannabis review by the U.S. Food and Administration (FDA), CBD manufacturers joined with academics, consumer packaged goods manufacturers and agriculture officials to ask a panel of regulators to give the cannabis industry a uniform set of guidelines for producing, packaging and labeling cannabis extracts.

Link to story: https://cnb.cx/2HStVYk